Worldquant Millennium Advisors LLC trimmed its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 7.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 195,511 shares of the technology company’s stock after selling 15,249 shares during the quarter. Worldquant Millennium Advisors LLC owned 0.12% of Veeva Systems worth $41,106,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in VEEV. MassMutual Private Wealth & Trust FSB increased its stake in shares of Veeva Systems by 72.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock worth $25,000 after acquiring an additional 50 shares during the period. Centricity Wealth Management LLC acquired a new position in shares of Veeva Systems during the fourth quarter worth about $25,000. Smithfield Trust Co increased its stake in shares of Veeva Systems by 145.5% during the fourth quarter. Smithfield Trust Co now owns 135 shares of the technology company’s stock worth $27,000 after acquiring an additional 80 shares during the period. Avion Wealth increased its stake in shares of Veeva Systems by 635.0% during the fourth quarter. Avion Wealth now owns 147 shares of the technology company’s stock worth $30,000 after acquiring an additional 127 shares during the period. Finally, Venturi Wealth Management LLC increased its stake in shares of Veeva Systems by 2,716.7% during the fourth quarter. Venturi Wealth Management LLC now owns 169 shares of the technology company’s stock worth $36,000 after acquiring an additional 163 shares during the period. 88.20% of the stock is currently owned by institutional investors and hedge funds.
Veeva Systems Price Performance
Shares of NYSE VEEV opened at $240.80 on Wednesday. Veeva Systems Inc. has a 12-month low of $170.25 and a 12-month high of $258.93. The company has a market capitalization of $39.18 billion, a PE ratio of 59.46, a price-to-earnings-growth ratio of 1.89 and a beta of 0.96. The firm’s 50-day moving average is $229.01 and its two-hundred day moving average is $226.69.
Analyst Ratings Changes
Read Our Latest Report on VEEV
Insider Buying and Selling at Veeva Systems
In related news, insider Thomas D. Schwenger sold 1,200 shares of the company’s stock in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $220.97, for a total transaction of $265,164.00. Following the transaction, the insider now owns 25,889 shares of the company’s stock, valued at approximately $5,720,692.33. This represents a 4.43% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Jonathan Faddis sold 787 shares of the company’s stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $226.20, for a total transaction of $178,019.40. Following the transaction, the senior vice president now directly owns 8,668 shares in the company, valued at $1,960,701.60. The trade was a 8.32% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 5,869 shares of company stock valued at $1,284,917 over the last quarter. Corporate insiders own 10.30% of the company’s stock.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Read More
- Five stocks we like better than Veeva Systems
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Top 5 Stocks Hedge Funds Are Buying Right Now
- Using the MarketBeat Dividend Tax Calculator
- Viking Holdings Posts Strong Q1, Eyes Growth Ahead
- 3 REITs to Buy and Hold for the Long Term
- 2 Reasons Netflix’s 40% Rally Is Far From Over
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.